David Parker, PhD
Articles
CMS to Cover Next-Gen Sequencing for Cancer: Implications for MCOs
June 1st 2018In a decision reached through the joint FDA/CMS Parallel Review process, CMS has granted national Medicare coverage to next-generation sequencing tests approved or cleared by the FDA as companion diagnostics for cancer therapies. This is clearly a win for Medicare beneficiaries and some NGS test providers-but is it also good news for MCOs?
Read More
Latest Updated Articles
Published: February 25th 2025 | Updated: February 28th 2025
Gaps in Diabetes Patient Education and Rising Healthcare Costs
Published: February 16th 2025 | Updated: February 19th 2025
Many Aging Vietnam War Vets Are Still Battling PTSD, Along With Chronic Illnesses, That Combat Exposure May Make More Likely, New Research Finds
Published: February 5th 2025 | Updated: February 7th 2025
A Key Ingredient to ‘Food is Medicine’: Standardization
Published: January 30th 2025 | Updated: January 31st 2025
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Published: June 25th 2025 | Updated: July 4th 2025
Diagnosing Type 1 Diabetes: Clinical Challenges and Consequences
Published: June 27th 2025 | Updated: July 4th 2025
Navigating Healthcare's Future: An Insider's View on Network Strategy, Employer Innovation and Policy Challenges
